Results 81 to 90 of about 2,643,317 (205)
Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment [PDF]
Background: t(9;22) is a balanced translocation, and the chromosome 22 breakpoints (Philadelphia chromosome – Ph+) determine formation of different fusion genes that are associated with either Ph+ acute lymphatic leukemia (Ph+ ALL) or chronic myeloid ...
Xiaomin Zheng +15 more
core +2 more sources
Arterial Occlusive Events in a Patient With Chronic Myeloid Leukemia Treated With Ponatinib
Arterial occlusive events (AOE) are rare adverse event in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor such as ponatinib. We treated a 47‐year‐old woman with chronic myeloid leukemia.
Osamu Imataki, Makiko Uemura
doaj +1 more source
Activating mutations in the gene encoding for receptor of colony stimulating factor 3 (CSF3R) are drivers of pathogenesis in chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML).
Marc S. Schwartz, Matthew J. Wieduwilt
doaj +1 more source
Inflammatory and Immunological Basis of Periodontal Diseases
The periodontal lesion emerges as an evolving immunological battlefield, where host–microbiome interactions, dysregulated immune responses, fragile resolution mechanisms, and inflammophilic dysbiosis converge to shift the balance from homeostasis to unrestrained tissue destruction.
Giacomo Baima +3 more
wiley +1 more source
Is There Any Relationship between Bilateral Pleural Effusion and Blast Crisis in Chronic Myeloid Leukemia? [PDF]
Pleural effusion in chronic myeloid leukemia (CML) has been rarely reported in medical practice. Additionally, the correlation of pleural effusion with blast crisis is unknown.
Mükerrem SAFALI +3 more
core +1 more source
Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia [PDF]
s Karyotypic evolution is a well-known phenomenon in patients with malignant hernatological disorders during disease progression. We describe a 50-year-old male patient who had originally presented with pancytopenia in October 1992.
Wunderlich, Bettina +18 more
core +1 more source
Oral Lichenoid Lesions in Patients With Dyskeratosis Congenita: A Retrospective Case Series
ABSTRACT Background Dyskeratosis congenita (DKC) is a rare inherited multisystem disorder primarily affecting the mucocutaneous and hematopoietic systems. Classically, it presents with the ectodermal triad of reticulate skin pigmentation, nail dystrophy, and oral leukoplakia.
Yehuda Zadik +9 more
wiley +1 more source
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
Imatinib is a tyrosine-kinase inhibitor that binds to ABL proteins and induces cytogenetic remissions in patients with chronic myeloid leukemia (CML). In these patients measuring response by molecular techniques is clearly required.
ALBERTI D +57 more
core +1 more source
MODELLING CHRONIC MYELOID LEUKEMIA IN ZEBRAFISH [PDF]
MODELLING CHRONIC MYELOID LEUKEMIA IN ZEBRAFISHMODELLING CHRONIC MYELOID LEUKEMIA IN ...
VARINELLI, MARCO
core
The majority of patients with chronic myeloid leukemia (CML) present with BCR::ABL1 transcripts involving the b2a2 (e13a2) and/or b3a2 (e14a2) junctions. However, a small subset of cases exhibit atypical breakpoints.
Shanfeng Hao +3 more
doaj +1 more source

